Search

Your search keyword '"Brucker, Sara Y."' showing total 35 results

Search Constraints

Start Over You searched for: Author "Brucker, Sara Y." Remove constraint Author: "Brucker, Sara Y." Publisher elsevier bv Remove constraint Publisher: elsevier bv
35 results on '"Brucker, Sara Y."'

Search Results

1. Pembrolizumab in combination with nab-paclitaxel for the treatment of patients with early-stage triple-negative breast cancer – A single-arm phase II trial (NeoImmunoboost, AGO-B-041)

2. Machine Learning and Patient-reported Outcomes for Longitudinal Monitoring of Disease Progression in Metastatic Breast Cancer: A Multicenter, Retrospective Analysis

4. Functional characteristics of a broad spectrum of TBX6 variants in Mayer-Rokitansky-Küster-Hauser syndrome

6. Occurrence and characteristics of patients with de novo advanced breast cancer according to patient and tumor characteristics – A retrospective analysis of a real world registry

7. Disseminated tumour cells from the bone marrow of early breast cancer patients: Results from an international pooled analysis

8. Prognostic effect of low-level HER2 expression in patients with clinically negative HER2 status

9. Functional annotation of the 2q35 breast cancer risk locus implicates a structural variant in influencing activity of a long-range enhancer element

10. Perturbations of genes essential for Müllerian duct and Wölffian duct development in Mayer-Rokitansky-Küster-Hauser syndrome

11. Corrigendum to “Initial experience with CDK4/6 inhibitor-based therapies compared to antihormone monotherapies in routine clinical use in patients with hormone receptor positive, HER2 negative breast cancer — Data from the PRAEGNANT research network for the first 2 years of drug availability in Germany”

12. Breast Cancer Polygenic Risk Score and Contralateral Breast Cancer Risk

13. Initial experience with CDK4/6 inhibitor-based therapies compared to antihormone monotherapies in routine clinical use in patients with hormone receptor positive, HER2 negative breast cancer — Data from the PRAEGNANT research network for the first 2 years of drug availability in Germany

14. Mismatch repair deficiency as a predictive marker for response to adjuvant radiotherapy in endometrial cancer

15. Correction: TERT promoter mutation in adult granulosa cell tumor of the ovary

16. Quality of life measurement in breast cancer patients: Reliability of an ePRO tool using EORTC QLQ-C30

17. Screening and evaluation of potential recipients and donors for living donor uterus transplantation: results from a single-center observational study

18. Polygenic Risk Scores for Prediction of Breast Cancer and Breast Cancer Subtypes

19. TERT promoter mutation in adult granulosa cell tumor of the ovary

21. MyD88 and TLR4 Expression in Epithelial Ovarian Cancer

22. Treatment landscape of advanced breast cancer patients with hormone receptor positive HER2 negative tumors – Data from the German PRAEGNANT breast cancer registry

23. Impact of disease progression on health-related quality of life in patients with metastatic breast cancer in the PRAEGNANT breast cancer registry

33. MyD88 and TLR4 Expression in Epithelial Ovarian Cancer

34. Functional annotation of the 2q35 breast cancer risk locus implicates a structural variant in influencing activity of a long-range enhancer element

35. Breast Cancer Polygenic Risk Score and Contralateral Breast Cancer Risk

Catalog

Books, media, physical & digital resources